3,5-Disubstituted Isoxazole Derivatives: Potential Inhibitors of Inflammation and Cancer
- 12 September 2015
- journal article
- research article
- Published by Springer Nature in Inflammation
- Vol. 39 (1) , 269-280
Abstract
The products of arachidonic acid metabolism by lipoxygenase (LOX) and cyclooxygenase (COX) significantly contribute to inflammation and carcinogenesis. Particularly, overproduction of leukotrienes and prostaglandins contribute to tumor growth by inducing formation of new blood vessels that sustain tumor cell viability and growth. Hence, search for novel anticancer drug via inhibition of LOX and COX enzymes constitutes an impressive strategy till date. In this context, a series of isoxazole derivatives were synthesized and screened for their anti-inflammatory activity via LOX and COX inhibition. Among these, 3-(3-methylthiophen-2-yl)-5-(3,4,5-trimethoxyphenyl)isoxazole (2b) showed significant inhibitory activity toward LOX and COX-2. Additionally, 2b showed a good inhibition of tumor growth, peritoneal angiogenesis, and ascite formation in Ehrlich ascites carcinoma (EAC) cell mouse model. Further, the in silico molecular studies also revealed that the compound 2b binds to the catalytic domain of LOX and COX-1 and COX-2 strongly with high atomic contact energy (ACE) score compared to standard drug. These initial pharmacological data support the fact that the compound 2b serves as the basis in developing anti-inflammatory and anticancer agents.Keywords
This publication has 39 references indexed in Scilit:
- Anti-cancer activity of novel dibenzo[b,f]azepine tethered isoxazoline derivativesBMC Chemical Biology, 2012
- Anti-Tumor Activity of a Novel HS-Mimetic-Vascular Endothelial Growth Factor Binding Small MoleculePLOS ONE, 2012
- Cyclooxygenases and lipoxygenases in cancerCancer and Metastasis Reviews, 2011
- Control of the growth of human breast cancer cells in culture by manipulation of arachidonate metabolismBMC Cancer, 2007
- Pro-apoptotic activity of imidazole derivatives mediated by up-regulation of Bax and activation of CAD in Ehrlich Ascites Tumor cellsInvestigational New Drugs, 2007
- Cardiovascular Events Associated with Rofecoxib in a Colorectal Adenoma Chemoprevention TrialNew England Journal of Medicine, 2005
- Inflammation and cancerNature, 2002
- Lipoxygenase Inhibitors Abolish Proliferation of Human Pancreatic Cancer CellsBiochemical and Biophysical Research Communications, 1999
- Patterns and Emerging Mechanisms of the Angiogenic Switch during TumorigenesisCell, 1996
- Prostaglandin synthase 2Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1996